Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
The fifth reviewed GLP-1 treatments for type 2 diabetes, and none of the treatments studied were sublingual
J., Mousa, A., & Joham, A
2013;37(11):1514 and 2015;39(1):187]
Funding Work in the authors groups has been supported by the National Institute for Translational Neuroscience (Brazil), the Brazilian agencies Conselho Nacional de Desenvolvimento Cientfico e Tecnolgico (CNPq) and Fundao de Amparo Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to STF and FDF), and Alzheimer Society Canada and Weston Brain Institute (to FDF)
Journal of Immunology (Baltimore, Md.: 1950), 187 (3), 12011206
US$ 27.14
US$ 22.56
US$ 24.09
US$ 27.64
US$ 27.81
US$ 22.54
